Related Experiment Videos
[Hürthle cell tumors: personal experience]
G De Toma1, R Gabriele, G Sgarzini
1Istituto di Clinica Chirurgica, Università degli Studi, La Sapienza, Roma.
Il Giornale Di Chirurgia
|May 1, 1995
Summary
Hürthle cell neoplasms are rare thyroid tumors. Diagnosis and malignancy indicators like invasion and necrosis are key for managing these uncommon Hürthle cell tumors.
Area of Science:
- Endocrinology
- Surgical Oncology
- Pathology
Background:
- Hürthle cell tumors represent a small fraction (3%) of well-differentiated thyroid neoplasms.
- Histological diagnosis can be challenging, with recent criteria emphasizing at least 75% oxyphil cells for Hürthle cell neoplasms.
- Malignancy indicators include extracapsular invasion, vascular invasion, capsular penetration, specific DNA patterns, and tumoral necrosis.
Purpose of the Study:
- To report the clinical experience in managing patients with Hürthle cell neoplasms.
- To discuss histological findings, surgical strategies, and post-operative follow-up for these tumors.
Main Methods:
- Retrospective analysis of 46 patients who underwent thyroid surgery for Hürthle cell neoplasms.
- Review of histological findings, including criteria for Hürthle cell neoplasm diagnosis and malignancy indicators.
- Evaluation of surgical approaches and post-operative follow-up data.
Main Results:
- The study involved the management of 46 patients diagnosed with Hürthle cell neoplasms.
- Histological features, surgical interventions, and outcomes were analyzed.
- Key indicators for malignancy were identified and discussed in relation to patient management.
Conclusions:
- Hürthle cell neoplasms require careful histological evaluation and consideration of malignancy indicators.
- Surgical management and post-operative follow-up are crucial components in the care of these patients.
- Further research may elucidate optimal treatment strategies for Hürthle cell tumors.